Overview

Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy

Status:
Completed
Trial end date:
2003-08-06
Target enrollment:
Participant gender:
Summary
The objectives of this study were to assess the tolerability and safety of E2007 in patients with refractory partial or generalised seizures and to assess the pharmacokinetics of E2007 in epileptic patients receiving at least one concomitant anti-epileptic drug.
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Co., Ltd.